Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Revenue of Elekta AB (publ) (EKTA-B.ST)
Revenue in 2023 (TTM): $1.64 B
According to Elekta AB (publ)'s latest financial reports the company's current revenue (TTM) is $1.64 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Elekta AB (publ)
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $1.64 B | $615.16 M | $298.73 M | $151.41 M | $118.18 M |
| 2022 | $1.53 B | $576.31 M | $233.19 M | $108.74 M | $85.6 M |
| 2021 | $1.32 B | $493.52 M | $248.35 M | $136.25 M | $104.75 M |
| 2020 | $1.25 B | $509.23 M | $284.57 M | $147.96 M | $113.83 M |
| 2019 | $1.33 B | $557.06 M | $271.04 M | $131.98 M | $98.4 M |
| 2018 | $1.23 B | $515.58 M | $245.26 M | $143.42 M | $108.74 M |
| 2017 | $1.03 B | $431.07 M | $233.74 M | $124.72 M | $99.76 M |
| 2016 | $971.61 M | $401.84 M | $116.46 M | $30.86 M | $11.35 M |
| 2015 | $1.02 B | $418.73 M | $99.58 M | $17.16 M | $12.44 M |
| 2014 | $983.87 M | $390.86 M | $131.16 M | $64.99 M | $50.11 M |
| 2013 | $970.71 M | $421.81 M | $196.25 M | $136.34 M | $104.21 M |
| 2012 | $938.48 M | $434.07 M | $217.94 M | $163.39 M | $121.63 M |
| 2011 | $821.3 M | $382.78 M | $200.06 M | $155.04 M | $111.38 M |
| 2010 | $717.46 M | $332.86 M | $160.12 M | $132.89 M | $93.59 M |
| 2009 | $670.98 M | $309.17 M | $133.34 M | $108.2 M | $75.61 M |
| 2008 | $607.17 M | $275.13 M | $98.76 M | $70.26 M | $49.56 M |
| 2007 | $461.21 M | $198.06 M | $78.61 M | $56.64 M | $36.85 M |
| 2006 | $410.74 M | $176.28 M | $63.27 M | $46.02 M | $31.59 M |
| 2005 | $401.3 M | $172.65 M | $59.82 M | $40.3 M | $27.59 M |
| 2004 | $286.11 M | $113.46 M | $42.39 M | $34.31 M | $22.97 M |
| 2003 | $263.24 M | $101.39 M | $33.31 M | $29.5 M | $22.51 M |
| 2002 | $252.43 M | $92.86 M | $33.86 M | $28.77 M | $21.24 M |
| 2001 | $248.53 M | $94.4 M | $22.97 M | $20.06 M | $13.16 M |